CVE-2023-51141 | BDVDB-2026-228259 Detail

zktecobiotime

Description#

An issue in ZKTeko BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information via the Authentication & Authorization component

Impact#

Per CVSS v3.1: confidentiality impact high, integrity impact none, availability impact none. Attack vector: network.

Weaknesses#

CWE-639 Authorization Bypass Through User-Controlled Key

References#

https://gist.github.com/ipxsec/1680d29c49fe368be81b037168175b10

Exploit#

No public exploit known

History#

Version 12024-03-21Record published in the CVE List.
Version 22026-07-09Most recent update recorded in the CVE List.

Published

Published: 2024-03-21
Last modified: 2026-07-09

Vendor information

Vendor: zkteco
Product: biotime

All zkteco vulnerabilities

Score

6.5 Medium

EPSS

less than 1%, Very Low

Estimated chance of exploitation in the next 30 days. EPSS percentile: 51.8.

KEV

Not listed in the CISA Known Exploited Vulnerabilities catalog.

Impact

Insecure Direct Object Reference

Action

No specific action is recorded in the source data. Check the references for vendor guidance.

Affected Systems

Vulnerable
8.5.4
Fixed
Not stated

Scoring System

CVSS v4.0

Not available

CVSS v3.1

6.5 Medium

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Metric breakdown
Attack Vector	Network
Attack Complexity	Low
Privileges Required	Low
User Interaction	None
Scope	Unchanged
Confidentiality	High
Integrity	None
Availability	None

CVSS v3.0

Not available

CVSS v2

Not available

Source: CVE List v5 (record); CISA KEV (kev, action); FIRST EPSS (epss).